Does cilengitide deserve another chance?-Authors' reply

Roger Stupp; Martin Picard; Michael Weller

doi:10.1016/S1470-2045(14)71121-0

Does cilengitide deserve another chance?-Authors' reply

Roger Stupp^*, Martin Picard, Michael Weller

^*Corresponding author for this work

Neurological Surgery

Research output: Contribution to journal › Letter

7 Scopus citations

Original language	English (US)
Pages (from-to)	e585-e586
Journal	The Lancet Oncology
Volume	15
Issue number	13
DOIs	https://doi.org/10.1016/S1470-2045(14)71121-0
State	Published - Jan 1 2014

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(14)71121-0

Cite this

Stupp, R., Picard, M., & Weller, M. (2014). Does cilengitide deserve another chance?-Authors' reply. The Lancet Oncology, 15(13), e585-e586. https://doi.org/10.1016/S1470-2045(14)71121-0

@article{df3260c9d6a04746aef2d919701ff335,

title = "Does cilengitide deserve another chance?-Authors' reply",

author = "Roger Stupp and Martin Picard and Michael Weller",

year = "2014",

month = jan,

day = "1",

doi = "10.1016/S1470-2045(14)71121-0",

language = "English (US)",

volume = "15",

pages = "e585--e586",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "13",

}

TY - JOUR

T1 - Does cilengitide deserve another chance?-Authors' reply

AU - Stupp, Roger

AU - Picard, Martin

AU - Weller, Michael

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84925228279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925228279&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(14)71121-0

DO - 10.1016/S1470-2045(14)71121-0

M3 - Letter

C2 - 25456377

AN - SCOPUS:84925228279

VL - 15

SP - e585-e586

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 13

ER -